{"title":"2010","authors":"Merritt Moseley","doi":"10.1017/9781139979672.017","DOIUrl":null,"url":null,"abstract":"This review was conducted in accordance with the statutory mandate for the Office of Inspector General (OIG) to compare average sales prices (ASP) and average manufacturer prices (AMP) for Medicare Part B prescription drugs and identify ASPs that exceed AMPs by at least 5 percent. The review also estimated the financial impact of lowering reimbursement amounts for drugs that exceeded the 5-percent threshold to 103 percent of the AMP, pursuant to statute.","PeriodicalId":356494,"journal":{"name":"Los 25 años de la OMC: Una retrospectiva fotográfica","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Los 25 años de la OMC: Una retrospectiva fotográfica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/9781139979672.017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This review was conducted in accordance with the statutory mandate for the Office of Inspector General (OIG) to compare average sales prices (ASP) and average manufacturer prices (AMP) for Medicare Part B prescription drugs and identify ASPs that exceed AMPs by at least 5 percent. The review also estimated the financial impact of lowering reimbursement amounts for drugs that exceeded the 5-percent threshold to 103 percent of the AMP, pursuant to statute.